SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-025269
Filing Date
2021-10-13
Accepted
2021-10-13 08:00:47
Documents
14
Period of Report
2021-10-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38507
2 ex99-1.htm EX-99.1 31052
3 ex99-1_001.jpg GRAPHIC 3003
  Complete submission text file 0001493152-21-025269.txt   253692

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vbiv-20211013.xsd EX-101.SCH 3034
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vbiv-20211013_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vbiv-20211013_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3589
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 211320188
SIC: 2834 Pharmaceutical Preparations